share_log

Possible Turnaround For Agilon Health Insiders, Still Down US$382k

Possible Turnaround For Agilon Health Insiders, Still Down US$382k

Agilon Health Insiders可能出現轉機,但仍下跌了38.2萬美元
Simply Wall St ·  04/21 22:58

Insiders who purchased US$747.9k worth of agilon health, inc. (NYSE:AGL) shares over the past year recouped some of their losses after price gained 10% last week. However, the purchase is proving to be an expensive wager as insiders are yet to get ahead of their losses which currently stand at US$382k since the time of purchase.

購買了價值74.79萬美元的agilon Health, inc.的內部人士紐約證券交易所代碼:AGL)在上週價格上漲10%之後,股價在過去一年中收復了部分跌幅。但是,事實證明,此次收購是一項昂貴的賭注,因爲內部人士尚未克服自收購以來的虧損,目前虧損爲38.2萬美元。

Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.

儘管我們認爲股東不應簡單地關注內幕交易,但我們確實認爲密切關注內部人士的所作所爲是完全合乎邏輯的。

agilon health Insider Transactions Over The Last Year

Agilon Health 去年的內幕交易

In the last twelve months, the biggest single purchase by an insider was when President Steven Sell bought US$498k worth of shares at a price of US$11.14 per share. That means that even when the share price was higher than US$5.46 (the recent price), an insider wanted to purchase shares. Their view may have changed since then, but at least it shows they felt optimistic at the time. We always take careful note of the price insiders pay when purchasing shares. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price.

在過去的十二個月中,內部人士最大的一次收購是總裁史蒂芬·塞爾以每股11.14美元的價格購買了價值49.8萬美元的股票。這意味着,即使股價高於5.46美元(最近的價格),內部人士也想購買股票。從那以後,他們的觀點可能發生了變化,但至少這表明他們當時感到樂觀。我們始終仔細注意內部人士在購買股票時支付的價格。通常,如果內部人士以高於當前價格的價格購買股票,我們對股票的看法會更加樂觀,因爲這表明他們認爲股票即使價格更高,也物有所值。

While agilon health insiders bought shares during the last year, they didn't sell. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

儘管agilon Health內部人士在去年購買了股票,但他們並沒有賣出。你可以在下面看到過去 12 個月內幕交易(公司和個人)的直觀描述。如果你想確切地知道誰賣了、賣了多少以及何時出售,只需點擊下圖!

insider-trading-volume
NYSE:AGL Insider Trading Volume April 21st 2024
紐約證券交易所:AGL 內幕交易量 2024 年 4 月 21 日

agilon health is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

agilon Health 並不是內部人士唯一買入的股票。因此,看看這份免費的內幕收購成長型公司名單。

Insider Ownership Of agilon health

agilon Health 的內部所有權

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. agilon health insiders own about US$31m worth of shares. That equates to 1.4% of the company. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

查看公司的內部持股總量可以幫助你了解他們是否與普通股股東保持一致。我們通常希望看到相當高的內部所有權。agilon Health Insiders擁有價值約3100萬美元的股票。這相當於該公司的1.4%。當然,我們在其他地方看到了更高的內部所有權水平,但這些持股足以表明內部人士與其他股東之間的一致性。

What Might The Insider Transactions At agilon health Tell Us?

agilon Health 的內幕交易能告訴我們什麼?

There haven't been any insider transactions in the last three months -- that doesn't mean much. However, our analysis of transactions over the last year is heartening. Insiders own shares in agilon health and we see no evidence to suggest they are worried about the future. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing agilon health. You'd be interested to know, that we found 2 warning signs for agilon health and we suggest you have a look.

在過去的三個月中,沒有任何內幕交易——這並不意味着什麼。但是,我們對去年交易的分析令人鼓舞。內部人士持有agilon Health的股份,我們沒有發現任何證據表明他們對未來感到擔憂。除了了解正在進行的內幕交易外,確定敏捷健康面臨的風險也是有益的。你可能會有興趣知道,我們發現了 2 個 agilon 生命值的警告信號,我們建議你看看。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

如果你想看看另一家公司——一家財務狀況可能優越的公司——那麼千萬不要錯過這份免費的股本回報率高、債務低的有趣公司的名單。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論